Dr Orest Lastow presenting Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies
Iconovo to present at New Updates in Drug Formulation & Bioavailability in Copenhagen August 28th. Dr Orest Lastow, CTO at Iconovo will present on the topic of Systemic Delivery of Biologics via Inhalation: Overcoming Injection Aversion in Modern Therapies
Biologic compounds, including proteins, RNA, and antibodies, have revolutionized disease treatment with their high specificity and efficacy. Traditionally, these biologics are administered as subcutaneous injections or infusions. However, patient aversion to injections often leads to delayed use of these treatments, despite their efficacy. When treating respiratory diseases, local delivery directly to the lungs is well-established and enables lower dosages to achieve the desired therapeutic effect. In addition, the lung and nose offer a route to systemic circulation due to its large surface area and thin epithelial layer, facilitating rapid and effective drug absorption, as demonstrated by inhaled insulin. Iconovo has developed inhaled formulations for biologics, proving the feasibility of pulmonary delivery and providing a compelling alternative to traditional injection-based therapies.
To register, follow the link:
https://lnkd.in/dcQNxCZr